CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today that Ivana Magovcevic-Liebisch, General Counsel and Executive Vice President of Corporate Communications, will present at the 8th Annual Mass Opportunities Investor Conference, being held on November 2nd at the Hilton Logan Airport Hotel in Boston, MA. Dr. Magovcevic-Liebisch will present a corporate progress report, including an update on the Company’s clinical development programs. The Dyax Corp. presentation is scheduled for Thursday, November 2 at 1:30 pm (ET).
